Alpine Global Management’s ProKidney PROK Stock Holding History

Alpine Global Management’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,186	Closed	-$19.9K	–	258
2023 Q4	$19.9K	Buy	+11,186	New	+$24K	0.01%	181

Other funds holding PROK

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alpine Global Management's PROK Position: Q1 2024 in Review

Alpine Global Management sold out of ProKidney (PROK) in Q1 2024, closing a stake of 11,186 shares — an estimated $19.9K sold.

Alpine Global Management first reported a position in PROK in Q4 2023 and held it in 1 quarter. The position peaked at $19.9K in Q4 2023. 55 funds tracked by Wall St. Rank hold PROK as of Q1 2024.

Alpine Global Management reported no remaining ProKidney position as of Q1 2024 after selling out during the quarter.
Alpine Global Management sold 11,186 ProKidney shares in Q1 2024, an estimated $19.9K.
Alpine Global Management first reported a position in ProKidney in Q4 2023 and held it in 1 quarter.
Alpine Global Management's ProKidney position peaked at $19.9K in Q4 2023.
55 funds tracked by Wall St. Rank held ProKidney as of Q1 2024.

Based on Alpine Global Management's 13F filing for Q1 2024, filed 15 May 2024.